Directs the Commission for Mental Health, Developmental Disabilities, and Substance Use Services (Commission) to amend the rules applicable to outpatient opioid treatment programs, as specified, to be more consistent with the federal regulations governing medications for the treatment of opioid use disorder.

Mandates that the Commission’s changes must include (1) removing the patient eligibility criteria of a stable home environment and social relationships, (2) explicitly prohibiting discharge from treatment due to continued substance use, missed doses, and nonparticipation in ancillary services like counseling, (3) removing structured counseling session schedules, (4) reducing the number of drug tests, (5) removing the requirement for observed urine testing, and (6) explicitly permitting opioid treatment programs to administer methadone to patients who are not enrolled with the program.

Specifies that the Commission must engage with current and former treatment program clients and providers for input on how to align requirements with the federal regulations and improve patient care.

Requires the Commission to publish proposed text of amended rules by July 1, 2025.